Association of the renin-sodium profile with the risk of myocardial infarction in patients with hypertension.
暂无分享,去创建一个
J. Laragh | W. L. Ooi | M. Alderman | H. Cohen | J. Sealey | S. Madhavan | J. Sealey
[1] H. Baumgartner,et al. Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury. , 1989, Science.
[2] J. Laragh,et al. On the renal basis for essential hypertension: nephron heterogeneity with discordant renin secretion and sodium excretion causing a hypertensive vasoconstriction-volume relationship. , 1988, Journal of hypertension.
[3] R. Peto,et al. Beta blockade during and after myocardial infarction: an overview of the randomized trials. , 1985, Progress in cardiovascular diseases.
[4] T. Meade,et al. The epidemiology of plasma renin. , 1983, Clinical science.
[5] J. Sealey. Measurement of the hormones of the renin system in hypertensive patients. , 1981, Clinical biochemistry.
[6] J. Laragh,et al. Prorenin and other large molecular weight forms of renin. , 1980, Endocrine reviews.
[7] M. Alderman,et al. Hypertension control at the work site. , 1976, Journal of occupational medicine. : official publication of the Industrial Medical Association.
[8] R Shapiro,et al. Interference by 2, 3-dimercapto-1-propanol (BAL) in angiotensin I radioimmunoassay. , 1976, The Journal of laboratory and clinical medicine.
[9] C. Gomez-Sanchez,et al. The intravenous furosemide test: a simple way to evaluate renin responsiveness. , 1976, Annals of internal medicine.
[10] M. Alderman,et al. Detection and treatment of hypertension at the work site. , 1975, The New England journal of medicine.
[11] J. Laragh. Vasoconstriction-volume analysis for understanding and treating hypertension: the use of renin and aldosterone profiles. , 1973, The American journal of medicine.
[12] J. Laragh,et al. Renin as a risk factor in essential hypertension: more evidence. , 1973, The American journal of medicine.
[13] E. Freis. Age, race, sex and other indices of risk in hypertension. , 1973, The American journal of medicine.
[14] J. Laragh,et al. Propranolol inhibition of renin secretion. A specific approach to diagnosis and treatment of renin-dependent hypertensive diseases. , 1972, The New England journal of medicine.
[15] J. Laragh,et al. Renin, angiotensin and aldosterone system in pathogenesis and management of hypertensive vascular disease. , 1972, The American journal of medicine.
[16] J. Laragh,et al. Essential hypertension: renin and aldosterone, heart attack and stroke. , 1972, The New England journal of medicine.
[17] J. Brown,et al. Acute renal failure, tubular necrosis, and myocardial infarction induced in the rabbit by intravenous angiotensin II. , 1971, Lancet.
[18] J. Laragh. The role of aldosterone in man. Evidence for regulation of electrolyte balance and arterial pressure by a renal-adrenal system which may be involved in malignant hypertension. , 1960, JAMA.
[19] M. Winternitz,et al. Studies on the Relation of the Kidney to Cardiovascular Disease , 1942, The Yale journal of biology and medicine.